Table 1 Summary table of baseline and endline characteristics
| Â | Baseline | Endline | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Arombe | GodKwer | Total | p value | Arombe | GodKwer | Total | p value | Baseline | Endline | Total | p value |
N participants at baseline (3 months prior to intervention rollout and data collection) | ||||||||||||
| Â | 369 | 338 | 707 | Â | 494 | 400 | 894 | Â | 707 | 894 | 1601 | Â |
Age | ||||||||||||
≤ 14 | 7 (1.9%) | 1 (0.3%) | 8 (1.1%) | 0.004 | 4 (0.8%) | 7 (1.8%) | 11 (1.2%) | 0.153 | 8 (1.1%) | 11 (1.2%) | 19 (1.2%) | 0.388 |
15–19 | 100 (27.1%) | 94 (27.8%) | 194 (27.4%) |  | 137 (27.7%) | 88 (22.0%) | 225 (25.2%) |  | 194 (27.4%) | 225 (25.2%) | 419 (26.2%) |  |
20–24 | 132 (35.8%) | 101 (29.9%) | 233 (33.0%) |  | 166 (33.6%) | 122 (30.5%) | 288 (32.2%) |  | 233 (33.0%) | 288 (32.2%) | 521 (32.5%) |  |
25–29 | 80 (21.7%) | 65 (19.2%) | 145 (20.5%) |  | 98 (19.8%) | 91 (22.8%) | 189 (21.1%) |  | 145 (20.5%) | 189 (21.1%) | 334 (20.9%) |  |
30–34 | 31 (8.4%) | 39 (11.5%) | 70 (9.9%) |  | 55 (11.1%) | 57 (14.3%) | 112 (12.5%) |  | 70 (9.9%) | 112 (12.5%) | 182 (11.4%) |  |
≥ 35 | 19 (5.1%) | 38 (11.2%) | 57 (8.1%) |  | 29 (5.9%) | 27 (6.8%) | 56 (6.3%) |  | 57 (8.1%) | 56 (6.3%) | 113 (7.1%) |  |
Parity | ||||||||||||
Median [Min, Max] | 1.00 [0, 8.00] | 1.00 [0, 14.0] | 1.00 [0, 14.0] | 0.0538 | 1.00 [0, 15.0] | 1.00 [0, 15.0] | 1.00 [0, 15.0] | 0.0298 | 1.00 [0, 14.0] | 1.00 [0, 15.0] | 1.00 [0, 15.0] | 0.769 |
Gravidae | ||||||||||||
Median [Min, Max] | 2.00 [1.00, 11.0] | 2.00 [1.00, 15.0] | 2.00 [1.00, 15.0] | 0.00425 | 2.00 [1.00, 16.0] | 2.00 [1.00, 16.0] | 2.00 [1.00, 16.0] | 0.0262 | 2.00 [1.00, 15.0] | 2.00 [1.00, 16.0] | 2.00 [1.00, 16.0] | 0.89 |
Gestation in weeks (time at which baseline participants initiated their first ANC visit during pregnancy) | ||||||||||||
≤ 13 | 18 (4.9%) | 14 (4.1%) | 32 (4.5%) | 0.039 | 41 (8.3%) | 42 (10.5%) | 83 (9.3%) | 0.416 | 32 (4.5%) | 83 (9.3%) | 115 (7.2%) | < 0.001 |
14–27 | 138 (37.4%) | 158 (46.7%) | 296 (41.9%) |  | 251 (50.8%) | 188 (47.0%) | 439 (49.1%) |  | 296 (41.9%) | 439 (49.1%) | 735 (45.9%) |  |
> 27 | 212 (57.5%) | 164 (48.5%) | 376 (53.2%) |  | 199 (40.3%) | 160 (40.0%) | 359 (40.2%) |  | 376 (53.2%) | 359 (40.2%) | 735 (45.9%) |  |
Number of baseline women making 1st, 2nd, 3rd or 4th recommended ANC visits | ||||||||||||
1st visit | 101 (27.4%) | 92 (27.2%) | 193 (27.3%) | 0.079 | 148 (30.0%) | 119 (29.8%) | 267 (29.9%) | 0.73 | 193 (27.3%) | 267 (29.9%) | 460 (28.7%) | 0.145 |
2nd visit | 88 (23.8%) | 73 (21.6%) | 161 (22.8%) | Â | 116 (23.5%) | 88 (22.0%) | 204 (22.8%) | Â | 161 (22.8%) | 204 (22.8%) | 365 (22.8%) | Â |
3rd visit | 83 (22.5%) | 61 (18.0%) | 144 (20.4%) | Â | 110 (22.3%) | 80 (20.0%) | 190 (21.3%) | Â | 144 (20.4%) | 190 (21.3%) | 334 (20.9%) | Â |
4th visit | 57 (15.4%) | 80 (23.7%) | 137 (19.4%) | Â | 65 (13.2%) | 63 (15.8%) | 128 (14.3%) | Â | 137 (19.4%) | 128 (14.3%) | 265 (16.6%) | Â |
> 4th visit | 36 (9.8%) | 32 (9.5%) | 68 (9.6%) |  | 52 (10.5%) | 37 (9.3%) | 89 (10.0%) |  | 68 (9.6%) | 89 (10.0%) | 157 (9.8%) |  |